Loading...
Loading...
Among the 3 tracked institutional investors we monitor, GTBP (GT BIOPHARMA INC) is held with a combined value of $30.84K across 75,573 shares. The largest holder is CITADEL ADVISORS LLC with a position worth $27.00K (0.00% of their portfolio). FMR LLC opened a new position in the most recent quarter. 2 funds reduced their position.
Total Institutional Value
$30.84K
Total Shares Held
75,573
Institutional Holders
3
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | $27.00K | 0.00% | -18.1% |
| 2 | BlackRock, Inc. | $3.43K | 0.00% | -0.0% |
| 3 | FMR LLC | $408 | 0.00% | New |
As of the latest SEC 13F filings, CITADEL ADVISORS LLC is the largest institutional holder of GTBP with a position worth $27.00K, representing 0.00% of their portfolio. In total, 3 institutional investors hold GTBP with a combined value of $30.84K.
In the most recent quarter, 1 fund opened a new position in GTBP. Additionally, 2 reduced their positions.
Institutional investors hold $30.84K worth of GTBP stock across 3 positions. The largest institutional holder is CITADEL ADVISORS LLC with $27.00K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For GTBP, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their GTBP positions.